%A Ferrari,Stefano %A Gentili,Christian %D 2016 %J Frontiers in Genetics %C %F %G English %K cancer therapy,checkpoint,DNA Damage,Mitosis,Phosphorylation,ubiquitylation %Q %R 10.3389/fgene.2016.00128 %W %L %M %P %7 %8 2016-July-21 %9 Review %+ Dr Stefano Ferrari,Institute of Molecular Cancer Research, University of Zurich,Zurich, Switzerland,sferrari@imcr.uzh.ch %# %! PTMs and mitotic DNA damage %* %< %T Maintaining Genome Stability in Defiance of Mitotic DNA Damage %U https://www.frontiersin.org/articles/10.3389/fgene.2016.00128 %V 7 %0 JOURNAL ARTICLE %@ 1664-8021 %X The implementation of decisions affecting cell viability and proliferation is based on prompt detection of the issue to be addressed, formulation and transmission of a correct set of instructions and fidelity in the execution of orders. While the first and the last are purely mechanical processes relying on the faithful functioning of single proteins or macromolecular complexes (sensors and effectors), information is the real cue, with signal amplitude, duration, and frequency ultimately determining the type of response. The cellular response to DNA damage is no exception to the rule. In this review article we focus on DNA damage responses in G2 and Mitosis. First, we set the stage describing mitosis and the machineries in charge of assembling the apparatus responsible for chromosome alignment and segregation as well as the inputs that control its function (checkpoints). Next, we examine the type of issues that a cell approaching mitosis might face, presenting the impact of post-translational modifications (PTMs) on the correct and timely functioning of pathways correcting errors or damage before chromosome segregation. We conclude this essay with a perspective on the current status of mitotic signaling pathway inhibitors and their potential use in cancer therapy.